Autoantibody profiling in systemic lupus erythematosus

References

• Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibodies explosion on systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum. 2004;35(2):501–537.
   Google Scholar
• Schroeder K, Herrmann M, Winkler TH. The role of somatic hypermutation in the generation of pathogenic antibodies in SLE. Autoimmunity. 2013;46(2):121–127.
   PubMed Web of Science ®Google Scholar
• Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science. 2003;301(5639):1374–1377.
   Google Scholar
• Munoz LE, Lauber K, Schiller M, Manfredi AA, Hessrnann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol. 2010;6(5):280–289.
   PubMed Web of Science ®Google Scholar
• Waisman A, Mendlovic S, Ruiz PJ, Zinger H, Meshores A, Mozes E. The role of the 16/6 idiotype network in the induction and manifestations of systemic lupus erythematosus. Int Immunol. 1993;5(10):1293–1300.
   Web of Science ®Google Scholar
• Yurasov S, Wardemann H, Hammersen J, et al. Defective B cell tolerance in systemic lupus erythematosus. J Exp Med. 2005;201(5):703–711.
   PubMed Web of Science ®Google Scholar
• Routsias JG, Tzioufas AG. B-cell epitopes of intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of autoimmune response. J Autoimmun. 2010;35(3):256–264.
   PubMed Web of Science ®Google Scholar
• Routsias JG, Vlachroyiannopoulous PG, Tzioufas AG. Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response. Crit Rev Clin Lab Sci. 2006;43(3):203–248.
   Web of Science ®Google Scholar
• Pickering MC, Botto M, Taylor PR, Lawchmann PJ, Walport MJ. Systemic lupus erythematosus complement deficiency and apoptosis. AdvImmunol. 2000;76:227–324.
   Web of Science ®Google Scholar
• Sjöwall C, Wetlero J. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins. Clin Chim Acta. 2007;378(1–2):13–23.
   Web of Science ®Google Scholar
• Dhillon V Latchman D, Isenberg D. Heat shock proteins and systemic lupus erythematosus. Lupus. 1991;1(1):3–8.
   Web of Science ®Google Scholar
• Prabhakar BS, Saegusa J, Onodera T, Notkins AL. Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire. J Immunol. 1984;133(6):2815–2817.
   PubMed Web of Science ®Google Scholar
• Hurez V Dietrich G, Kaveir SV, Kazatchkine MD. Polyreactivity is a property of natural and disease-associated human autoantibodies. Scand J Immunol. 1993:38(2):190–196.
   Web of Science ®Google Scholar
• Zhang J, Jacobi AM, Wang T, Berlin RA, Volpe BT, Diamond B. Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential. J Autoimmun. 2009;33(3–4):270–274.
   PubMed Web of Science ®Google Scholar
• Dimitrov JD, Pashov AD, Vassilev TL. . Antibody polyspecificity: what does it matter. In: Lutz HU, editor. Naturally Occurring Antibodies (NAbs). Heidelberg: Springer; 2012.
   Google Scholar
• Ruiz-Argüelles A, Rivadeneyra-Espinoza L, Alarcón-Segovia D. Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications. Curr Pharm Des. 2003;9(23):1881–1887.
   Web of Science ®Google Scholar
• Martin T, Crouzier R, Weber JC, Kipps TJ, Pasquali JL. Structure- function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequence in the third complementarity-determining region of the antibody heavy chain. J Immunol. 1994;152(12):5988–5996.
   PubMed Web of Science ®Google Scholar
• Ditzel HJ, Itoh K, Burton DJ. Determinants of polyreactivity in a large panel of recombinant human antibodies from HIV-1 infection. J Immunol. 1996;157(2):739–749.
   PubMed Web of Science ®Google Scholar
• James LC, Tawfik DS. The specificity of cross-reactivity: promiscuous antibody binding involves specific hydrogen bonds rather than non-specific hydrophobic stickiness. Protein Sci. 2003;12(10):2183–2193.
   Web of Science ®Google Scholar
• Weller S, Conde C, Knapp AM, et al. Autoantibodies in mice lacking terminal deoxynucleotidyl transferase: evidence for a role of N region addition in the polyreactivity and in the affinity of anti-DNA antibodies. J Immunol. 1997;159(8):3890–3898.
   Web of Science ®Google Scholar
• Alarcón-Segovia D, Llorente L, Ruíz-Argüelles A. The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by dysregulation and/or cell damage. J Autoimmun. 1996;9(2):295–300.
   PubMed Web of Science ®Google Scholar
• Ruíz-Argüelles A, Pérez-Romano B, Llorente L, Alarcón-Segovia D, Castellanos JM. Penetration of anti-DNA antibodies into mature live cells. J Autoimmun. 1998;11(5):547–556.
   Web of Science ®Google Scholar
• Kurien BT, Scofield RH. Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand J Immunol. 2006;64(3):227–235.
   Web of Science ®Google Scholar
• Liu CC, Ahearn JM. The search for lupus biomarkers. Best Pract Res Clin Rheumatol. 2009;23(4):507–523.
   PubMed Web of Science ®Google Scholar
• Ahearn JM, Liu CC, Kao AH, Manzi S. Biomarkers for systemic lupus erythematosus. Transí Res. 2012;159(4):326–342.
   PubMed Web of Science ®Google Scholar
• Rekvig OP, Putterman C, Casu C, et al. Autoantibodies in lupus: culprits or passive bystanders? Autoimmun Rev. 2012:11(8):596–603.
   PubMed Web of Science ®Google Scholar
• Zhen QL, Xie C, Wu T, et al. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest. 2013;115(15):3428–3439.
   Google Scholar
• Hockberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
   Google Scholar
• Bizzaro N, Villalta D, Giavarina D, Tozzoli R. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies in systemic lupus erythematosus? A systemic view and a study of metanalysis. Autoimmu Rev. 2012;12(2):97–106.
   PubMed Web of Science ®Google Scholar
• Weisbart RH, Garrett RA, Liebling MR, Barnett EV, Paulus HE, Katz DH. Specificity of anti-nucleoside antibodies in systemic lupus erythematosus. Clin Immunol Immunopathol. 1983;27(3):403–411.
   Google Scholar
• Bambardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35(6):630–640.
   Google Scholar
• Symmons DP, Coppock JS, Bacon PA, et al. Development and assessment of a computerized idea of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J Med. 1998;79(1):927–937.
   Google Scholar
• Natali S, Karim MY. Autoantibodies as markers for detecting concurrent disease activity in systemic lupus erythematosus. Transl Res. 2010;156(6):317–319.
   Web of Science ®Google Scholar
• Flierman R, Daha MR. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis–a hypothesis. Mol Immunol. 2007;44(1–3):133–138.
   Web of Science ®Google Scholar
• Pickering M, Botto M. Are anti-C1q antibodies different from other SLE autoantibodies? Nat Rev Rheumatol. 2010;6(8):490–493.
   PubMed Web of Science ®Google Scholar
• Diamond B, Volpe BT. A model for lupus brain disease. Immunol Rev. 2012;248(1):56–67.
   Google Scholar
• Seret G, Le Meur Y, Renaudineau Y, Youinou P. Mesangial cell-specific antibodies are central to the pathogenesis of lupus nephritis. Clin Dev Immunol. 2012;2012:579670.
   PubMedGoogle Scholar
• Satoh M, Vázquez-Del Mercado M, Chan EKL. Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases. Mod Rheumatol. 2009;19(3):219–228.
   PubMed Web of Science ®Google Scholar
• Hanly JG, Thompson K, McCurdy G, Fougere L, Thercault C, Wilton K. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus. J Immunol Methods. 2010;352(1–2):147–153.
   PubMed Web of Science ®Google Scholar
• Kim Y, Park Y, Lee EY, Kim HS. Comparison of automated multiplexed bead-based ANA screen assay with ELISA for detecting five common anti-extractable nuclear antigens and anti-dsDNA in systemic lupus erythematosus. Clin Chim Acta. 2012;413(1–2):308–311.
   PubMed Web of Science ®Google Scholar
• Eriksson C, Kokkonen H, Johansson H, Hallmans G, Wadell G, Rantapää-Dahlqvist S. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Res Ther. 2011;13(1):R30.
   PubMed Web of Science ®Google Scholar
• Yu CL, Chang KL, Chiu CC, Chiang BN, Han SH, Wang SR. Alteration of mitogenic responses of mononuclear cells by anti-dsDNA antibodies resembling immune disorders in patients with systemic lupus erythematosus. Scand J Rheumatol. 1989;18(5):265–276.
   PubMed Web of Science ®Google Scholar
• Tsai CY, Wu TH, Sun KH, Yu CL. Effects of antibodies to double stranded DNA, purified from serum samples of patients with active systemic lupus erythematosus, on the glomerular mesangial cells. Ann Rheum Dis. 1992;51(2):162–167.
   Web of Science ®Google Scholar
• Sun KH, Liu WT, Tsai CY, Tang SJ, Han SH, Yu CL. Anti-dsDNA antibodies cross-react with ribosomal P proteins expressed on the surface of glomerular mesangial cells to exert a cytostatic effect. Immunology. 1995;85(2):262–269.
   Web of Science ®Google Scholar
• Du H, Chen M, Zhang Y, Zhao MH, Wang HY. Cross-reaction of antiDNA autoantibodies with membrane proteins of human glomerular mesangial cells in sera from patients with lupus nephritis. Clin Exp Immunol. 2006;145(1):21–27.
   Web of Science ®Google Scholar
• Yung S, Zhang Q, Zhang CZ, Chan KW, Lui SL, Chan TM. Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid. Arthritis Rheum. 2009;60(7):2071–2082.
   PubMedGoogle Scholar
• Yung S, Cheung KF, Zhang Q, Chan YM. Anti-DNA antibodies bind to mesangial annexin II in lupus nephritis. J Am Soc Nephrol. 2010;21(11):1912–1927.
   PubMed Web of Science ®Google Scholar
• Fenton KA, Tommeras B, Marion TN, Rekvig OP. Pure anti-daDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice. Autoimmunity. 2010;43(2):179–188.
   Web of Science ®Google Scholar
• Sun KH, Liu WT, Tang SJ, et al. The expression of acidic ribosomal phosphoproteins on the surface membrane of different tissues in autoimmune and normal mice which are the target molecules for antidouble-stranded DNA antibodies. Immunology. 1996;87(3):362–371.
   PubMed Web of Science ®Google Scholar
• Sun KH, Hong CC, Tang SJ, et al. Anti-dsDNA autoantibody cross- reacts with the C-terminal hydrophobic cluster region containing phenylalanines in the acidic ribosomal phosphoprotein P1 to exert a cytostatic effect on the cells. Biochem Biophys Res Commun. 1999;263(2):334–339.
   Web of Science ®Google Scholar
• Yu CL, Sun KH, Tsai CY, Hsieh SC, Yu HS. Anti-dsDNA antibody up-regulates interleukin-6, but not cyclooxygenase, gene expression in glomerular mesangial cells: a marker of immune-mediated renal damage? Inflamm Res. 2001;50(1):12–18.
   Web of Science ®Google Scholar
• Hsieh SC, Sun KH, Tsai CY, et al. Monoclonal anti-double stranded DNA antibody is a leukocyte binding protein to up-regulate interleukin-8 gene expression and elicit apoptosis of normal human polymorphonuclear neutrophils. Rheumatology (Oxford). 2001;40(8):851–858.
   Web of Science ®Google Scholar
• Luan HY, Tang SJ, Yang W, Tsai CY, Sun GH, Sun KH. Monoclonal anti-double-stranded DNA antibodies cross-react with phosphoglycerate kinase 1 and inhibit the expression and production of IL-2 in activated Jurkat T cell line. Clin Immunol. 2006;120(3):326–334.
   Web of Science ®Google Scholar
• Song YC, Tang SJ, Lee TP, et al. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice. Arthritis Rheum. 2010;62(8):2401–2411.
   Google Scholar
• Lee TP, Tang SJ, Wu MF, Song YC, Yu CL, Sun KH. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus. J Autoimmun. 2010;35(4):358–367.
   Web of Science ®Google Scholar
• Song YC, Sun GH, Lee TP, et al. Arginines in the CDR of anti-dsDNA autoantibodies facilitate cell internalization via electrostatic interactions. Eur J Immunol. 2008;38(11):3178–3190.
   Web of Science ®Google Scholar
• Lisi S, Sisto M, Lofrumento DD, D’Amore S, D’Amore M. Advances in the understanding of the Fc gamma receptors-mediated autoantibodies uptake. Clin Exp Med. 2011;11(1):1–10.
   Web of Science ®Google Scholar
• Carreras LO, Defreyn G, Machin SJ, et al. Arterial thrombosis, intrauterine death and lupus anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet. 1981;317(8214):244–246.
   Google Scholar
• Hughes GR. Thrombosis, abortion, cerebral disease, and the lupus coagulant. Br Med J (Clin Res Ed). 1983;287(8):1088–1089.
   Google Scholar
• Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GR. Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol. 1984;2(1):47–51.
   Google Scholar
• Hamsten A, Norberg R, Bjorkholm M, DeFaire U, Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet. 1986;1(8473):113–115.
   Web of Science ®Google Scholar
• Englert HJ, Derue GM, Loizou S, et al. Pregnancy and lupus: prognostic indicators and response to treatment. Q J Med. 1988;66(250):125–136.
   Google Scholar
• Alarcón-Segovia D, Cardiel MH, Reyes E. Antiphospholipid arterial vasculopathy. J Rheumatol. 1989;16(5):762–767.
   Google Scholar
• Arad A, Proulle V, Furie RA, Furie BC, Furie B. p2-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. Blood. 2011;117(12):3453–3459.
   Web of Science ®Google Scholar
• Vista ES, Crowe SR, Thompson LF, et al. Influenza vaccination can induce new-onset anticardiolipins but not (32-glycoprotein-I antibodies among patients with systemic lupus erythematosus. Lupus. 2012;21(2):168–174.
   Web of Science ®Google Scholar
• Cederholm A, Frostegard J. Annexin A5 in cardiovascular disease and systemic lupus erythematosus. Immunobiology. 2005;210(10):761–768.
   Web of Science ®Google Scholar
• Frostegård AG, Su J, Landenberg P, Frostegård J. Effects of anti- cardiolipin antibodies and IVIG on annexin A5 binding to endothelial cells: implications for cardiovascular disease. Scand J Rheumatol. 2010;39(1):77–83.
   PubMed Web of Science ®Google Scholar
• Lin WS, Chen PC, Yang CD, et al. Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases. Arthritis Rheum. 2007;56(5):1638–1647.
   Google Scholar
• Moroni PL, Borghi OB, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol. 2011;7(6):330–339.
   Web of Science ®Google Scholar
• Misra R, Venables PJ, Plater-Zyberk C, Watkins PF, Maini RN. Anti-cardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes. Clin Exp Immunol. 1989;75(1):35–40.
   Web of Science ®Google Scholar
• Yu CL, Sun KH, T sai CY, Wang SR. Inhibitory effects of anticardiolipin antibodies on lymphocyte proliferation and neutrophil phagocytosis. Ann Rheum Dis. 1991;50(12):903–908.
   Web of Science ®Google Scholar
• Sun KH, Liu WT, Tsai CY, Liao TS, Lin WM, Yu CL. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. Ann Rheum Dis. 1992;51(6):707–712.
   Web of Science ®Google Scholar
• Tsai CY, Yu CL, Wu TH, et al. Polyclonal anticardiolipin antibodies purified from sera of patients with active systemic lupus erythematosus induce apoptosis of the cultured glomerular mesangial cells. Scand J Rheumatol. 2000;29(6):370–379.
   Web of Science ®Google Scholar
• Bonfa E, Golombek SJ, Kaufman LD, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med. 1987;317(15):265–271.
   Google Scholar
• Martin AL, Reichlin M. Fluctuations of antibody to ribosomal P proteins correlate with appearance and remission of nephritis in SLE. Lupus. 1996;5(1):22–29.
   Web of Science ®Google Scholar
• Toubi E, ShoenfeldY. Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun Rev. 2007;6(3):119–125.
   Web of Science ®Google Scholar
• Sun KH, Tang SJ, Lin ML, Wang YS, Sun GH, Liu WT. Monoclonal antibodies against ribosomal P proteins penetrate into living cells and cause apoptosis of Jurkat T cells in culture. Rheumatology (Oxford). 2001;40(7):750–756.
   Web of Science ®Google Scholar
• Sun KH, Tang SJ, Chen CY, et al. Monoclonal ribosomal P autoantibody inhibits the expression and release of IL-12, TNF-alpha and iNOS in activated RAW macrophage cell line. J Autoimmun. 2005;24(2):135–143.
   Web of Science ®Google Scholar
• Lee TP, Leu SJ, Huang JC, et al. Anti-ribosomal phosphoprotein autoantibody triggers interleukin-10 overproduction via phosphatidylinositol 3-kinase-dependent signalling pathways in lipopolysaccharide-activated macrophages. Immunology. 2009;127(1):91–102.
   Web of Science ®Google Scholar
• Lauvsnes MB, Omdal R. Systemic lupus erythematosus, the brain and anti-NR2 antibodies. J Neurol. 2012;259(4):622–629.
   Web of Science ®Google Scholar
• Efthimiou P, Blanco M. Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers. Mod Rheumatol. 2009;19(4):457–468.
   Google Scholar
• Buyon JP, Clancy RM. Neonatal lupus syndrome. Curr Opin Rheumatol. 2003;15(5):535–541.
   Google Scholar
• Hon KL, Leung AK. Neonatal lupus erythematosus. Autoimmun Dis. 2012;2012:301274.
   Google Scholar
• Li JM, Horsfall AC, Maini RN. Anti-La (SS-B) but not anti-Ro (SS-A) antibodies cross-react with laminin–a role in the pathogenesis of congenital heart block? Clin Exp Immunol. 1995;99(3):316–324.
   Web of Science ®Google Scholar
• Reed JH, Sim S, Wolin SL, Clancy RM, Buyon JR. Ro60 requires y3RNA for cell surface exposure and inflammation associated with cardiac manifestation of neonatal lupus. J Immunol. 2013;192(1):110–116.
   Google Scholar
• Starkebaum G, Price TH, Lee PM, Arend WP. Autoimmune neutropenia in systemic lupus erythematosus. Arthritis Rheum. 1978;21(5):504–512.
   Google Scholar
• Peng SL, Graft J. . Antinuclear antibodies. In: Ruddy S, editor. Kelley’s Textbook of Rheumatology. Philadelphia: WB Sanders; 2001:167–171.
   Google Scholar
• Hsieh SC, Yu HS, Lin WW, et al. Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus. Clin Exp Immunol. 2003;131(3):506–516.
   Web of Science ®Google Scholar
• Biswas D, Mathias A, Dayal R, Aggarwal A, Misra R, Naik S. Presence of antibodies to SSB/La is associated with decreased phagocytic efficiency of neutrophils in patients with systemic lupus erythematosus. Clin Rheumatol. 2008;27(6):717–722.
   Web of Science ®Google Scholar
• Minada-Carús ME, Askanase AD, Clancy RM, et al. Anti-SSA/Ro and anti-SSB/La autoantibodies bind to the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J Immunol. 2000;165(9):5345–5351.
   Web of Science ®Google Scholar
• Bouts YM, Wolthues DF, Dirks MF, et al. Apoptosis and NET formation in the pathogenesis of SLE. Autoimmunity. 2012;45(8):597–601.
   PubMed Web of Science ®Google Scholar
• Knight JS, Kaplan MJ. Lupus neutrophils: ‘NET’ gain in understanding lupus pathogenesis. Curr Opin Rheumatol. 2012;24(5):441–450.
   Web of Science ®Google Scholar
• Hanrotel-Saliou C, Segalen I, Meur YL, Youinou P, Renaudineau Y Glomerular antibodies in lupus nephritis. Clin Rev Allergy Immunol. 2011;40(3):151–158.
   Web of Science ®Google Scholar
• Faaber P Capel PJA, Riike GPM, Vierwinden G, van de Putte LBA, Koene RAP. Cross-reactivity of anti-DNA antibodies with proteoglycan. Clin Exp Immunol. 1984;55(3):502–508.
   Web of Science ®Google Scholar
• Yang HB, Zheng WJ, Zhang X, Tang FL. Induction of endothelial cell apoptosis by anti-alpha-enolase antibody. Chin Med Sci J. 2011;26(3):152–157.
   Google Scholar